期刊文献+

短期胰岛素强化治疗对围手术期高血糖患者胰岛β细胞功能的影响 被引量:4

Effects of short-term intensive insulin therapy in patients with hyperglycemia on beta cell function in perioperative period
下载PDF
导出
摘要 目的探讨短期胰岛素强化治疗对围手术期高血糖患者β细胞功能的影响。方法回顾性分析2011年1月~2013年7月我院短期胰岛素强化治疗围手术期高血糖的患者临床资料,其中采用持续性皮下胰岛素输注治疗患者25例(CSII组),采用多次皮下胰岛素注射治疗患者20例(MSII组)。治疗2周后,比较两组的血糖控制(FBG、2h PG、GSP)、β细胞功能、胰岛素敏感性指标以及TNF-α、IL-1β、CRP、APN的变化情况。结果 CSII组与MSII组的FBG、2h PG、GSP水平均较治疗前显著降低,差异具有统计学意义(P〈0.05);治疗后CSII组的FBG、2h PG、GSP水平与MSII组比较,差异不显著(P〉0.05)。CSII组与MSII组的GSP、Homa-IR水平均较治疗前显著降低,Homa-β较治疗前显著升高,且与MSII组比较改善更显著(P〈0.05);同样CSII组TNF-α、IL-1β、CRP水平与MSII组比较也改善更显著(P〈0.05)。结论持续性皮下胰岛素输注治疗可有效控制血糖,显著改善胰岛β功能及提高胰岛素敏感性,其机制可能与下调炎性因子有关。 Objective To explore the effect of short-term intensive insulin therapy in patients with hyperglycemia on beta cell function in perioperative period. Methods From January 2011 to July2013 in our hospital, forty-five patients in perioperative period with hyperglycemia were underwent short-term intensive therapy(continuous subcutaneous insulin infusion, CSII group, n =25; multiple subcutaneous insulin injection, MSII group, n =20). The data of FBG, 2h PG, blood glucose GSP,beta cell function and insulin sensitivity index and the changes of TNF- α, IL-1β, CRP and APN were compared between the two groups. Results After the treatment, the patients of CSII group and MSII group showed significantly decreased FBG, 2h PG and GSP levels(P〈0.05). Both CSII group and MSII group showed significantly lower FCP and Homa-IR levels, and higher Homa-β after treatment(P〈0.05). CSII group demonstrated more significantly improvement compared with MSII(P〈0.05). And the same changes of TNF-α, IL-1β, CRP, and APN levels were observed after treatment in CSII group compared with MSII group. Conclusion The continuous subcutaneous insulin therapy can effectively control blood glucose and improve islet function and insulin sensitivity,which is involved by reducing inflammation.
出处 《岭南现代临床外科》 2015年第3期283-285,共3页 Lingnan Modern Clinics in Surgery
关键词 围手术期 高血糖 胰岛素强化治疗 持续性皮下胰岛素输注 Perioperative period Hyperglycemia Intensive insulin therapy Continuous subcutaneous insulin therapy
  • 相关文献

参考文献8

  • 1Evans CH, Lee J, Ruhlman MK. Optimal glucose management in the perioperative period [J]. Surg Clin North Am, 2015, 95(2) : 337-354.
  • 2Kathleen M Dungan, Susan S, Braithwaite, et al. Stress hyperglycaemia [ J ]. Lancet, 2009, 373 ( 9677 ) : 1798-1807.
  • 3Cuthbertson DP. Observations on the disturbance of metabolismproduced by injury to the limbs [J]. Quart J Med, 1932, 25(1): 233-246.
  • 4Yendamuri S, Fulda GJ, Tinkoff GH. Admission hyperglycemia as aprognostic indicator in trauma [J]. J Trauma, 2003, 55 (1): 33-38.
  • 5Laird AM, Miller PR, Kilgo PD, et al. Relationship of early hyperglycemia to mortality in trauma patients [J]. J Trauma, 2004, 56(5) : 1058-1062.
  • 6Boulkina LS, Braithwaite SS. Practical aspects of intensive insulinization in the intensive care unit [J]. Curr Opin Clin Nutr Metab Care, 2007, 10(2): 197-205.
  • 7李延兵,翁建平,许雯,陈小华,廖志红,姚斌,邓婉萍,欧香忠,胡国亮.短期持续胰岛素输注治疗对初诊2型糖尿病患者胰岛β细胞功能的影响[J].中国糖尿病杂志,2003,11(1):10-15. 被引量:777
  • 8Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance [J]. Eur Cytokine Netw, 2006, 17(1) : 4-12.

二级参考文献10

  • 1Purrello F, Rabuazza AM. Metabolic factors that affect betacell function and survival. Diabet Nutr Metab, 2000, 13: 84-91.
  • 2Sivitz WI. Lipotoxieity and glueotoxieity in type 2 diabetes. Effects on development and progression. Postgrad Med, 2001,109: 55-59,63-64.
  • 3Lenhard M J, Reeves GD. Continous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med,2001,161: 2293-2300.
  • 4Dupuy O, Mayaudon H, Palou M, et al. Optimized transient insulin infusion in uneontrolled type 2 Diabetes : Evaluation of a pragmatie attitude. Diabet Med, 2000,26 : 371-375.
  • 5Valensi P, Moura I, Magoarou M,et al. Short-term effects of continuous subcutaneous insulin infusion treatment on insulin secretion in non-insulin-dependent overweight patients with poor glycaemic control despite maximal oral anti-diabetic treatment. Diabet Metab,1997,23: 51-57.
  • 6Lormeau B, Aurousseau MH, Valensi P, et al. Hyperinsulinemia and hypofibrinolysis: effects of short-term optimized glyeemic control with contineuous insulin infusion in type Ⅱ diabetie patients. Metabolism,1997,46: 1074-1079.
  • 7Ilkova H, Glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20:1353-1356.
  • 8Pratley RE, Weyer C. The role of impaired early insulin secretion in the pathogenesis of type II diabetes mellitus. Diabetologia 2001,44:929-945.
  • 9Del Prato S, Marchetti P, Bonadonna RC. Phasic insulin release and metabolic regulation in type 2 diabetes. Diabetes,2002, 51suppl 1: s109-116.
  • 10Kahn SE. The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus. Am J Med, 2000,108suppl 6a: 2s-8s.

共引文献776

同被引文献43

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部